Search Results

240 results for bmti

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

By Muslim Farooque, InvestorPlace Contributor

Capitalize on the biotech sector’s boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments

Why Rite Aid Corporation (RAD), General Electric Company (GE) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer

Rite Aid (RAD), Bristol-Myers Squibb (BMY) and General Electric (GE) ended the trading week on a bearish foot.

3 Cheap Dividend Stocks For High Total Returns

By Bob Ciura, Sure Dividend

Cheap dividend stocks can generate a double dose of returns, with dividends as well as capital appreciation through a rising share price.

5 Medical Devices Stocks to Sell Now

By Portfolio Grader

The ratings of five Medical Devices stocks are down this week, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or…

3 Undervalued Stock Gems Selling for 50 Cents on the Dollar

By Steve Booyens, CFA

Undervalued stock gems are abundant if you know where to look for them. Consider these three companies before someone else does.

BMTX Stock Earnings: BM Technologies Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings

BMTX stock results show that BM Technologies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

RMTI Stock Earnings: Rockwell Medical Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings

RMTI stock results show that Rockwell Medical beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

BMTX Stock Earnings: BM Technologies Misses EPS, Misses Revenue for Q4 2023

By InvestorPlace Earnings

BMTX stock results show that BM Technologies missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

RMTI Stock Earnings: Rockwell Medical Beats EPS, Misses Revenue for Q4 2023

By InvestorPlace Earnings

RMTI stock results show that Rockwell Medical beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

3 Defensive Stocks to Buy During the Market Dip

By Stavros Tousios, InvestorPlace Contributor

Clearway, Bristol-Myers Squibb and Universal Corp. are defensive stocks to buy on the dip, offering stable dividends and significant upside.

3 Ultra High-Yield Stocks With Sustainable Dividends to Buy Now

By Rich Duprey, InvestorPlace Contributor

Finding high-yield stocks with sustainable dividends is the key to offsetting the higher risk these investments bring.

3 Big Stock Charts for Monday: Bristol-Myers Squibb Co (BMY), Visa Inc (V) and Fiserv Inc (FISV)

By Johnson Research Group

Bristol-Myers (BMY) have rallied from a deeply oversold chart reading, while Visa’s (V) rally looks tempting and Fiserv (FISV) shares are sitting in a technical…

3 Pharmaceuticals to Profit on Obamacare

By Susan J. Aluise, Aviation, Auto & Transportation Writer

More people enrolling in health insurance, that likely means more prescriptions and ultimately more profits for pharmaceuticals.

Why Twitter Inc (TWTR), Bristol-Myers Squibb Co (BMY) and Twilio Inc (TWLO) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer

Twitter (TWTR), Bristol-Myers Squibb (BMY) and Twilio (TWLO) each uses more than their fair share of red ink on Monday.

SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

SMTI Stock Earnings: Sanara MedTech Misses EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings

SMTI stock results show that Sanara MedTech missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

SMTI Stock Earnings: Sanara MedTech Beats EPS, Beats Revenue for Q4 2023

By InvestorPlace Earnings

SMTI stock results show that Sanara MedTech beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

Weekly Upgrades and Downgrades

By Louis Navellier, Editor, Growth Investor

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to…

4 Pharmaceutical Stocks to Buy Now

By Portfolio Grader

The grades of four Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”)…

4 Pharmaceutical Stocks to Buy Now

By Portfolio Grader

The grades of four Pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”)…

4 Pharmaceutical Stocks to Buy Now

By Portfolio Grader

Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…

4 Pharmaceutical Stocks to Buy Now

By Portfolio Grader

This week, four Pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an “A” (“strong buy”) or “B”…

4 Pharmaceutical Stocks to Buy Now

By Portfolio Grader

Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an…

5 Top Dividend Stocks From Across the Globe

By Aaron Levitt, InvestorPlace Contributor

Looking for dividend stocks? Then you should check out overseas companies to get your yield. Here are five international stocks to consider.

6 – 10 of 240 results